Radiation-Armed Robot Rapidly Destroys Human Lung Tumors

Key points
- Although it is too early to determine the technique's long-term effectiveness, Ozhasoglu and his colleagues find promise in this new approach to treat lung cancer and other tumors that move during breathing.
- At the University of Pittsburgh, Ozhasoglu and approximately 30 colleagues form one of the largest US teams devoted to the CyberKnife, a radiation delivery system that uses an accurate, precise robotic arm to aim highly focused x-ray beams at the site of a tumor.
- Recently, the Pittsburgh researchers upgraded their CyberKnife by adding a system called "Synchrony," which accurately targets tumors that move as a result of breathing.
- Treating lung tumors with the enhanced Cyberknife requires only 1-3 sessions lasting 60-90 minutes.
Super-intense radiation delivered by a robotic arm eradicated lung tumors in some human patients just 3-4 months after treatment, medical physicist Cihat Ozhasoglu, Ph.D. of the University of Pittsburgh Medical Center will report in early August at the 48th Annual Meeting of the American Association of Physicists in Medicine in Orlando. Although it is too early to determine the technique's long-term effectiveness, Ozhasoglu and his colleagues find promise in this new approach to treat lung cancer and other tumors that move during breathing.
At the University of Pittsburgh, Ozhasoglu and approximately 30 colleagues form one of the largest US teams devoted to the CyberKnife, a radiation delivery system that uses an accurate, precise robotic arm to aim highly focused x-ray beams at the site of a tumor. Currently there are 76 active CyberKnife sites worldwide (with 45 in the US), and an additional 62 scheduled to be installed globally.
Recently, the Pittsburgh researchers upgraded their CyberKnife by adding a system called "Synchrony," which accurately targets tumors that move as a result of breathing. Synchrony instructs the robotic arm to move the radiation source (a linear accelerator that produces x-rays) in sync with the tumor motion.
As a result of the unique real-time tumor tracking capabilities of their upgraded CyberKnife, the researchers have established detailed methods for the safe treatment of lung tumors which otherwise couldn't be treated with a high dose of radiation due to lack of sufficient real-time tracking accuracy in other, more conventional radiation therapy machines.
Treating lung tumors with the enhanced Cyberknife requires only 1-3 sessions lasting 60-90 minutes. In conventional radiotherapy, patients must endure dozens of radiation treatments, each lasting about 15 minutes but requiring 20-30 hospital visits.
In a single treatment, Cyberknife blasts a lung tumor from all sides by delivering typically 100-150 intense, focused x-ray beams, causing the tumor to absorb approximately 10 times more radiation than in a conventional radiotherapy session. Cyberknife can deliver so much more radiation than other techniques because its robotic arm aims the x-rays precisely enough to avoid surrounding healthy tissue.
To track the moving tumor, the CyberKnife takes real-time x-ray pictures of the patient while using external markers attached to the patient's chest or abdomen to follow tumors in real time with a few millimeters of accuracy. The researchers also applied Synchrony to treating tumors in the thorax and abdomen, which can move as much as 4 cm during respiration.
Meeting Paper: WE-D-VaIA-4, "Synchrony - Real-Time Respiratory Compensation system for the CyberKnife," Wednesday, August 2, 2006, 2:20 PM, Room Valencia A.
Presented at: 48th Annual Meeting of the American Association of Physicists in Medicine, July 30-August 3, 2006, Orange County Convention Center, Orlando, FL.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsCommonly used drug can limit radiation damage to lungs and heart for cancer patients
Geneva, Switzerland: Unavoidable damage caused to the heart and lungs by radiotherapy treatment of tumours in the chest region can be limited by the administration of an ACE inhibitor, a drug commonly used in the…
22 April 2013
NewsBreast cancer radiation adds heart risk
Women treated with radiation for breast cancer are more likely to develop heart problems later, even with the lower doses used now, troubling new research suggests. The risk comes from any amount of radiation, starts…
15 March 2013
NewsNovel radiation therapy method shortens prostate cancer treatment time
According to a study in the January issue of the Journal of the American College of Radiology, the use of volume-modulated arc therapy (VMAT) to deliver intensity-modulated radiation therapy (IMRT) to prostate cancer…







